This pharma company received USDA approval for a generic drug which clocked over Rs 90 crore in sales, do you own it?
This pharma company received USDA approval for a generic drug which clocked over Rs 90 crore in sales, do you own it?

This pharma company received USDA approval for a generic drug which clocked over Rs 90 crore in sales, do you own it?

The company is ranked among the world’s top 100 biopharmaceutical companies and among the world’s top 50 companies in the off-patent sector.

Bhavya Rathod Article rating: 4.4

Glenmark Pharmaceuticals Ltd is an innovation-driven global pharmaceutical company with a presence across Specialty, Generics and OTC businesses

Overnight Digest: Stocks to be kept on radar for February 15
Overnight Digest: Stocks to be kept on radar for February 15

Overnight Digest: Stocks to be kept on radar for February 15

Sensex ended 3 per cent down at 56,405.84 levels whereas Nifty contracted 3.06 per cent settling at 16,842.80 level.

Shreya Chaware Article rating: 4.2

On Monday, the equity markets experienced a bearish day due to increasing tension between the US and Russia over Ukraine which caused a rise in oil prices and led investors to dump risky assets. Sensex ended 3 per cent down at 56,405.84 levels whereas Nifty contracted 3.06 per cent settling at 16,842.80 level. 

 

DSIJ MINDSHARE

Mkt Commentary15-May, 2024

Multibaggers15-May, 2024

Multibaggers15-May, 2024

Mindshare15-May, 2024

Multibaggers14-May, 2024

Knowledge

MF14-May, 2024

MF14-May, 2024

General13-May, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR